Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Auction Trading on Nasdaq FNGM

Ayima Group AB (publ) ("Ayima" or the "Company")  have the following information regarding trade in the Company share, AYIMA B. Starting January 18th AYIMA B will trade through the auction method introduced by Nasdaq for certain stocks on Nasdaq First North Growth Market. According to Nasdaq this aims to assure a better price structure for those stocks with low liquidity and high spread, that is the difference between buy- and sell prices. For more information, please refer to information from Nasdaq via the links below. IT Notice

CLS future-proofs its core technology for MRI-guided laser ablation in a new agreement with IGT

Lund, Sweden – Clinical Laserthermia Systems AB (publ) (CLS) today announces that a new agreement has been signed with its supplier Image Guided Therapy SA (IGT). Under the terms of the agreement, CLS will acquire all rights to IGT's technology for MRI-based temperature measurement and control of laser-based tissue ablation.The agreement is an important part of the development of the company's technology platform and business strategy. The agreement with IGT means that CLS now owns all rights to its product portfolio and can thus fully secure value creation in the continued work with

Belatra Shines Again with Golden Lantern Slot

This game will brighten up any slot player’s day thanks to its sharp design and uplifting soundtrack. Symbols are composed of a range of Oriental items that include handmade fans, blossoming lotus flowers and the famous Lucky Cat.The Scatter symbol is represented by the Yin-yang and finding four on the reels will grant 10 Free Games, five will return 15 Free Games and six will award 20 Free Games. Securing at least three Scatters in Free Games will trigger an additional five Free Games spins, the maximum is capped at 300. Once Free Games are triggered, there is the opportunity for the

Swedish TAGGR strengthens industry leadership with the acquisition of TRAKK, paving the way for European push for asset intelligence services

Taggr AB, a leading provider in asset intelligence services, is enhancing its position through the acquisition of Swedish companies Trackntrace Svenska AB and Trakk Telematics Solutions AB. With this acquisition, Taggr increases its presence and footprint in the asset intelligence space.The deal accelerates Taggr's ambition to deliver asset intelligence services across the entire European market. With Tagger’s ambitions of also becoming number one in asset intelligence in Europe, this is a key milestone that has been reached. Trakk is one of the leaders in the Nordic region and has

Invitation to SSAB’s briefing of the Year-end report 2023

SSAB invites you to a presentation of the Year-end report of 2023 at 9.30am CET on Wednesday, January 31, 2024. The report will be published at approximately 7.30am CET on the same date. The report will be presented by SSAB’s President and CEO Martin Lindqvist, and CFO Leena Craelius. The press conference will be held in English and live webcast on SSAB’s website www.ssab.com. Link to webcast: https://edge.media-server.com/mmc/p/2twb9ckz You can also participate in the briefing by telephone. Click on the link below and complete the online registration form. You can chose

ITAB delivers self-checkouts to leading grocery chain in Europe

ITAB Group (“ITAB”) has signed an agreement with a leading European grocery chain for the delivery of 7,200 self-checkouts for their stores in multiple countries. The implementation has begun and is estimated to be completed in February 2025. The total value of the contract is estimated for approximately MEUR 16 in 2024.Together with the customer, a leading European grocery chain, ITAB has developed a customised solution for self-checkouts in the chain’s stores. In this project, 7,200 self-checkouts will be rolled out for the chain in several countries, including Spain, Netherlands, Czech

UB FIGG led second part of EUR 27.5 million investment round in Paptic

United Bankers Plc PRESS RELEASE 17 January 2024 at 11.00 EET   UB FIGG led second part of EUR 27.5 million investment round in Paptic UB Forest Industry Green Growth Fund (UB FIGG) led the second part of EUR 27.5 million investment round in Paptic Ltd, a high-growth company manufacturing wood fibre-based packaging materials. Paptic made the second closing of the growth financing totaling EUR 4.5 million at the end of 2023. UB FIGG was joined by Emerald Technology Ventures, SIG InnoVentures, and EIC Fund in the round. In the first round (first closing) of the two-part growth

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 14 - 17 JANUARY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Elicera Therapeutics’ co-founder Magnus Essand invited to present the company's CAR T-cell projects at the world's largest cancer immunotherapy conference, CICON

Gothenburg, January 17, 2024 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company developing next generation cancer treatments based on its proprietary commercial technology platform iTANK, today announced that the company's Chief Scientific Officer and co-founder, Professor Magnus Essand, has received a prestigious speaking invitation from the Eighth International Cancer Immunotherapy Conference (CICON).CICON is the world's largest recurring conference in the field of cancer immunotherapy and is being held this year in Washington, DC, between September 8 and 11.

Viking Cinderella to be updated before returning to Helsinki service – the vessel's original interior solutions are now super-trendy

Hundreds of refurbished cabins that are even more comfortable, a fresh Scandinavian look and spa facilities inspired by the archipelago surroundings – Viking Cinderella is returning to service on the Helsinki–Stockholm route in better shape than ever. On board the vessel, which was built in 1989, passengers can also marvel at the original gleaming marble and copper, which are super-trendy interior design features today.The interiors on Viking Cinderella, built in 1989, have been updated numerous times over the course of the years. With its new facelift, the vessel has been spruced up in

Monitoring web service’s accessibility evolved into a cloud service

Helsinki, January 17, 2024 - Eficode has launched a new software as a service, Eficode Accessibility Keeper, designed for monitoring accessibility. The service automatically monitors the accessibility of web services, providing detailed and understandable information about the service's status and potential correction needs. Ensuring web service accessibility compliance with legal requirements Eficode developed the accessibility monitoring solution in response to directives and legislative requirements governing the provision of digital services. These regulations already, or soon

Read original

Arctic Bioscience – Recruitment completed in the phase IIb HeROPA clinical trial

With reference to the stock exchange announcement from December 1[st] 2023 which reported more than 75% patients recruited to the phase IIb clinical trial HeROPA, Arctic Bioscience is pleased to report that we have now fully recruited this phase IIb clinical trial in mild-to-moderate psoriasis with the planned 519 patients.The HeROPA trial is randomized, double blind and placebo controlled, investigating the efficacy and safety of the novel, oral drug candidate HRO350 for the treatment of mild-to-moderate psoriasis. The HeROPA trial is ongoing in 5 countries in Europe; UK, Germany, Poland,

The subscription period in Carbiotix AB’s preferential rights issue commences today

Today, the 17th of January 2024, the subscription period in Carbiotix AB’s ("Carbiotix" or "the Company") issue of units consisting of shares and consideration free warrants of series TO 3 (”TO 3”), with preferential right for the Company's existing shareholders begins. The subscription period runs until the 31st of January 2024. The issue volume initially amounts to a maximum of approximately SEK 18.7 million before transaction costs (the "Rights Issue"). Upon full subscription of the Rights Issue and full utilization of issued TO 3 at the highest subscription price, the Company may receive

BioStock: Cyxone identifies target protein for rabeximod

Cyxone has put intense focus on the development of lead candidate rabeximod - an immunomodulatory treatment for rheumatoid arthritis. The company has now produced important research results that provide a more detailed insight into the drug candidate's mechanism of action. The company's CEO Carl-Magnus Högerkorp tells us more in an interview.Read the full article at biostock.se : https://www.biostock.se/en/2024/01/cyxone-identifies-target-protein-for-rabeximod/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Clinical Laserthermia Systems’ business update: focus on accelerating commercial roll-out and updated sales ambitions

Lund, Sverige – Clinical Laserthermia Systems AB (publ) (CLS) will give an update at today’s business update event, presenting the company's strategic and its commercial roll-out, and provide an updated sales ambition.­­ Highlights that CLS will present at today’s business update event starting at 14:00 CET include near-term milestones for 2024-2026 to achieve the Company´s vision: Urology market segment · Entering into new agreements with commercial partners for continued expansion of sales and distribution in all regions to achieve 20 active users in the US and 15 active users

Alfa Laval's juice mixing plant minimizes environmental footprint for Denmark’s beverage producer CO-RO

Denmark’s beverage and home-freeze ice lolly producer CO-RO has chosen a complete juice mixing plant from Alfa Laval for its processing unit in Frederikssund, Denmark – and sustainability is one of the key enablers.With a rise in erratic climate changes, food and beverage producers are increasingly focused on mitigating related risks and building resilience into their set-up – such as making the most of raw materials with the lowest possible CO\2\ footprint. “We are witnessing concerns amongst food and beverage producers over resource depletion and a need to increase yields with lowest

Kesko ranks sector best on the ‘Global 100 Most Sustainable Corporations in the World’ listing, as the only company in the world to have made the list every year for two decades

Kesko has been ranked as the best company in its sector on the 2024 ‘Global 100 Most Sustainable Corporations in the World’ listing. Overall, Kesko ranked 29th on the list, making a significant leap upward. Kesko is the only company in the world to have made the list every year since its inception in 2005.The Canadian Corporate Knights has been publishing its listing of the world’s most sustainable companies for two decades. One key assessment criterion for the list is actions taken by the companies to mitigate climate change and reduce emissions. When it comes to the assessment of

Fostrox + Lenvima shows further improved response rates and time to progression in advanced liver cancer (HCC) at ASCO GI Symposium

· Overall Response Rate (ORR) has increased to 25% (local review RECIST 1.1) · Median time to progression continues to improve as data matures, now 5.1 months1 with >40% of patients still on treatment · Continued good safety and tolerability profile. Longest running patient still on treatment after ~17 months with sustained partial response   Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today further improved clinical benefit with fostrox +

Repurchase of Outokumpu’s own shares

Outokumpu OyjStock exchange releaseJanuary 17, 2024 at 9.30 am EETRepurchase of Outokumpu’s own shares On January 16, 2024, Outokumpu has completed repurchases of its own shares as follows (ISIN FI0009002422): +-------+----------------+------------------------------------+----------------+|Trading|Number of shares|Weighted average price / share, EUR*|Total cost, EUR*||venue | | | |+-------+----------------+------------------------------------+----------------+|  |  |

SKF to publish full-year results on 31 January

Gothenburg, 17 January 2024: SKF will publish its full-year results for 2023 on 31 January 2024 at approximately 07:00 (CET). Investors, analysts and media are invited to join a webcast, which will be held in English, at 08:00 (CET).   To join the webcast, please login at least 10 minutes before the start using the below link or phone numbers. Link to web event: https://www.investis-live.com/skf/659d1b8d9608da12002f8d22/lape 

NCC to refurbish Ågården in Copenhagen

NCC is to refurbish the Ågården neighborhood in Copenhagen’s Nörrebro district and work will now begin. The assignment is the first project to be carried out within the framework of the fsb HJEM partnership, which includes NCC. The order value of the project is approximately SEK 225 million. Image: NCC NCC has previously planned this project and has now been commissioned to refurbish 326 residential units across two large residential blocks. The refurbishment will take into account the ongoing operations of businesses and residents in the area. The Ågården neighborhood is

BioStock: Neola’s rapid development recognised at JPMorgan

The 42nd edition of the JPMorgan Health Conference took place last week, and one of the participants was Neola Medical. The Swedish medtech is currently preparing its lung monitoring system for a clinical study in the US. BioStock spoke to the company’s CEO Hanna Sjöström to get her impressions from the conference.Read the full article at biostock.se : https://www.biostock.se/en/2024/01/neolas-rapid-development-recognised-at-jpmorgan/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Artificial Solutions publishes information memorandum regarding the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE.On 13 December 2023, Artificial Solutions International AB (“Artificial Solutions” or the “Company”) announced that the board of directors had resolved on a rights issue of up to approximately SEK 25.6 million (the “Rights Issue”),

Green Hire Purchase Facility and further bond purchases

FIRSTGROUP PLC Green hire purchase facility and further bond purchases FirstGroup plc (the ‘Group’) is pleased to announce that it has signed a new, innovative £150m Green Hire Purchase Financing Facility with a syndicate of three banks to support the purchase of electric bus bodies (the chassis and drivetrain, excluding the battery) (the “Facility”). This follows the strategic Joint Venture with Hitachi to purchase up to 1,000 electric bus batteries announced by the Group in November 2023. The Facility provides the funding for electric bus bodies, net of any government co-funding

There are no items matching the current filter
There are no more items matching the current filter
Back to top